[Internal quality management: use of a patient questionnaire in a urological university clinic. Results of a pilot project].

C. Juhra,P. Hensen,G. Pühse,S. Wollert,N. Roeder

DOI: https://doi.org/10.1007/S00120-005-0891-8

2005-12-01

Abstract:

What problem does this paper attempt to address?

Diagnostic accuracy of metagenomic next-generation sequencing in diagnosing infectious diseases: a meta-analysis

Jian Liu,Qiao Zhang,Yong-Quan Dong,Jie Yin,Yun-Qing Qiu

DOI: https://doi.org/10.1038/s41598-022-25314-y

IF: 4.6

2022-01-01

Scientific Reports

Abstract:Many common pathogens are difficult or impossible to detect using conventional microbiological tests. However, the rapid and untargeted nature of metagenomic next-generation sequencing (mNGS) appears to be a promising alternative. To perform a systematic review and meta-analysis of evidence regarding the diagnostic accuracy of mNGS in patients with infectious diseases. An electronic literature search of Embase, PubMed and Scopus databases was performed. Quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Summary receiver operating characteristics (sROC) and the area under the curve (AUC) were calculated; A random-effects model was used in cases of heterogeneity. A total of 20 papers were eligible for inclusion and synthesis. The sensitivity and specificity of diagnostic mNGS were 75% and 68%, respectively. The AUC from the SROC was 85%, corresponding to excellent performance. mNGS demonstrated satisfactory diagnostic performance for infections and yielded an overall detection rate superior to conventional methods.
Higher diagnostic value of metagenomic next-generation sequencing in acute infection than chronic infection: a multicenter retrospective study

Anjie Yao,Jiale Wang,Qintao Xu,Binay Kumar Shah,Kai Sun,Feng Hu,Changhui Wang,Shuanshuan Xie

DOI: https://doi.org/10.3389/fmicb.2024.1295184

IF: 5.2

2024-01-31

Frontiers in Microbiology

Abstract:Background: The aim of this study is to compare the diagnostic value of metagenomic next-generation sequencing (mNGS) vs. conventional culture methods (CM) in chronic infection and acute infection. Methods: We retrospectively analyzed the bronchoalveolar lavage fluid (BALF) of 88 patients with acute infection and 105 patients with chronic infection admitted to three hospitals from 2017 to 2022. Results: The results showed that the sensitivity and specificity of mNGS were higher than those of CM. The number of patients who changed the antibiotic treatment in the mNGS positive group was larger than that of patients in the mNGS negative group in both the acute infection group (60.5 vs. 28.0%, P = 0.0022) and chronic infection group (46.2 vs. 22.6%, P = 0.01112). High levels of temperature (OR: 2.02, 95% CI: 1.18–3.70, P : 0.015), C-reactive protein (CRP) (OR: 15, 95% CI: 2.74–280.69, P : 0.011), neutrophil count (OR: 3.09, 95% CI: 1.19–8.43, P : 0.023), and low levels of lymphocyte count (OR: 3.43, 95% CI:1.26–10.21, P : 0.020) may lead to positive mNGS results in the acute infection group while no significant factor was identified to predict positive results in the chronic infection group. Conclusion: mNGS could provide useful guidance on antibiotic strategies in infectious diseases and may be more valuable for the diagnosis and treatment of acute infection vs. chronic infection.

microbiology
The diagnostic value of metagenomic next-generation sequencing in critically ill patients with sepsis: A retrospective cohort study

Chaozhong Li,Fang Wang,Wanrong Li,Guihu Sun,Dexing Yang,Ting Yang,Guohui Yang,Bo Liang,Yun Huang,Wenzhi Tang,Fei Li,Yujia Ye,Chuanyun Qian,Haiying Wu,Zhaohui Meng

DOI: https://doi.org/10.1097/md.0000000000039987

IF: 1.6

2024-10-15

Medicine

Abstract:Sepsis is a major healthcare problem that affects millions of people worldwide annually, and approximately 26.7% of sepsis patients die. [ 1–3 ] Early identification and proper management in the first few hours after sepsis can improve the prognosis; therefore, rapid and accurate identification of pathogenic bacteria is critical for successful outcomes. [ 4 ] A comprehensive routine microbiological test (CMT) is the traditional detection method of pathogenic microorganisms, which involves morphological detection, culture separation, biochemical detection, immunological tests, and nucleic acid detection. Because of its simplicity, rapidity, low technical requirements, and certain diagnostic sensitivity and specificity, CMT is still widely used in the clinic. Metagenomic next-generation sequencing (mNGS) is a new high-throughput sequencing method [ 5 ] that does not rely on traditional microbial culture to extensively analyze microbial groups (bacteria, fungi, viruses, and parasites) in clinical samples. By analyzing high-throughput sequencing and an intelligent algorithm, this technology can obtain the species information of suspected pathogenic microorganisms, thereby providing a nonbiased identification of bacteria, fungi, viruses, parasites, and other pathogenic microorganisms. [ 6 ] mNGS is suitable for patients with unexplained fever, difficult and critical illness, and immunodeficiency infection. [ 7–9 ] mNGS technology is also helpful to identify patients who may have bloodstream infections, particularly those with a fungal infection, mild symptoms, previous antibiotics, and early infection. [ 9 ] For patients with sepsis with abdominal infections, compared to the traditional methods of abdominal drainage smear, culture, and blood culture, plasma mNGS can provide early, noninvasive, and rapid microbiological diagnosis. [ 10 ] The mNGS technology should be considered an essential supplement to culture-based methods, particularly for unculturable or difficult-to-culture. [ 11 ] The mNGS is capable of identifying multiple pathogens in specimens from septic patients, and shows significantly higher positive rates than culture-based diagnostics. [ 12 ] The performance of mNGS in identifying pathogens for patients with sepsis is better than that of traditional detection methods, especially in immunocompromised patients. [ 13 ] This study aims to detect the difference between mNGS and CMT, and to explore the diagnostic efficacy of mNGS in critically ill patients with sepsis.

medicine, general & internal
Clinical application of metagenomic next-generation sequencing for the diagnosis of suspected infection in adults: A cross-sectional study

Chunping Sun,Chaoe Zhou,Lina Wang,Shanchen Wei,Mingwei Shi,Jun Li,Lianjun Lin,Xinmin Liu

DOI: https://doi.org/10.1097/md.0000000000037845

IF: 1.6

2024-04-20

Medicine

Abstract:Metagenomic next-generation sequencing (mNGS) has become an available method for pathogen detection. The clinical application of mNGS requires further evaluation. We conducted a cross-sectional study of 104 patients with suspected infection between May 2019 and May 2021. The risk factors associated with infection were analyzed using univariate logistic analysis. The diagnostic performance of pathogens was compared between mNGS and conventional microbiological tests. About 104 patients were assigned into 3 groups: infected group (n = 69), noninfected group (n = 20), and unknown group (n = 15). With the composite reference standard (combined results of all microbiological tests, radiological testing results, and a summary of the hospital stay of the patient) as the gold standard, the sensitivity, specificity, positive predictive value, negative predictive value of mNGS was 84.9%, 50.0%, 88.6%, and 42.1%, respectively. Compared with conventional microbiological tests, mNGS could detect more pathogens and had obvious advantages in Mycobacterium tuberculosis, Aspergillus, and virus detection. Moreover, mNGS had distinct benefits in detecting mixed infections. Bacteria–fungi–virus mixed infections were the most common in patients with severe pneumonia. mNGS had a higher sensitivity than conventional microbiological tests, especially for M. tuberculosis, Aspergillus, viruses, and mixed infections. We suggest that mNGS should be used more frequently in the early diagnosis of pathogens in critically ill patients in the future.

medicine, general & internal
Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital

DOI: https://doi.org/10.2147/IDR.S401707

2023-03-30

Infection and Drug Resistance

Abstract:Yang-Hua Xiao, 1, 2 Mei-Fang Liu, 1 Hongwen Wu, 1, 3 De-Rong Xu, 1 Rui Zhao 1 1 Department of Clinical Laboratory, Medical Center for Burn and Plastic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China; 2 School of Public Health, Nanchang University, Nanchang, People's Republic of China; 3 Department of Medical Instruments, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China Correspondence: De-Rong Xu; Rui Zhao, Email ; Purpose: Metagenomic next-generation sequencing (mNGS) is a powerful yet unbiased method to identify pathogens in suspected infections. However, little is known about its clinical effectiveness. The present study aimed to assess the efficacy of mNGS in routine clinical practice. Patients and Methods: In this single-center retrospective cohort study, 518 patients with suspected infectious diseases were assessed for inclusion. Among them, each patient had undergone mNGS testing; 407 patients had undergone both microbial culture and mNGS testing. The result of mNGS testing was compared to microbial culture performed concurrently. The diagnostic performance of mNGS was evaluated using the comprehensive clinical diagnosis as the reference standard. Results: There was a significant difference in the positive detection rates of pathogens between mNGS and culture (331/407, 81.3% vs 79/407, 19.4%, P < 0.001). The sensitivity of mNGS was much higher than the culture method (79.5% vs 21.3%, P < 0.001), especially in sample types of sputum and bronchoalveolar lavage fluid (BALF). Notably, the sensitivity of blood mNGS was relatively lower than other sample types (67.4% vs 88.9– 93.8%). Pathogen cfDNA load based on standardized stringently mapped read number at the species level of microorganisms (SDSMRN) was significantly lower in blood than in other sample types from the same patient ( P = 0.0003). Importantly, mNGS directly led to a change of treatment regimen in 142 (27.4%) cases, including antibiotic escalation (15.3%), antibiotic de-escalation (9.1%), and early definitive diagnosis to initiate appropriate treatment (3.1%). Conclusion: Our in-house mNGS platform significantly improved the sensitivity for the diagnosis of infectious diseases. mNGS has the potential to improve clinical outcomes by optimizing antimicrobial therapy. Keywords: mNGS, infections, diagnostic, outcome Infections are the major cause of human deaths worldwide and present a rising threat to public security. 1 Antimicrobial resistance is a major concern that is threatening our ability to treat bacterial infections. 2 Delayed administration of antibiotics significantly increases the in-hospital mortality rate. 3 The tragic outcome of infection highlights the importance of timely diagnosis and appropriate antibiotic treatment of advanced diseases. Conventional microbiologic culture and microscopy remain the gold standard for diagnostics. Full identification of fastidious microorganisms is usually reserved for cases where an isolate is in pure culture. 4,5 However, it is a laborious and time-consuming procedure requiring several days to accomplish. Additionally, the sensitivity of the culture method depends largely on the duration of the infection and whether the patient has previously received antibiotic treatment. 6 For these reasons, rapid and accurate identification of unknown pathogenic microorganisms is critical to guide clinical decision-making about diagnosis and treatment. Molecular methods, such as polymerase chain reaction (PCR), are an alternative method when culture-based microbial detection methods fail. 7,8 However, the preselected target pathogens greatly limit the application of multiplex PCR in identifying infections caused by mixed pathogens. 9 PCR-based analyses may fail to detect unexpected, rare, or novel pathogens unless multiplexed PCRs covering all pathogenic microorganisms are employed. The clinical symptoms and etiologies of multiple infections are complex and diverse, so it is difficult to diagnose using conventional microbial methods. 10,11 This may complicate further treatment (eg, delay antimicrobial treatment, lead to antibiotics overuse, prolong hospitalizations, and increase healthcare costs). Accurate and timely diagnosis is essential for aggressive antimicrobial adjustment. These barriers are not insurmountable obstacles to treating infectious diseases. Metagenomic next-generation sequencing (mNGS) is an untargeted molecular approach that can theoretically detect all potential pathogens in a single experiment. As a -Abstract Truncated-

pharmacology & pharmacy,infectious diseases
The clinical application of metagenomic next-generation sequencing in infectious diseases at a tertiary hospital in China

Chuwen Wang,Danying Yan,Jiajia Huang,Naibin Yang,Jiejun Shi,Shou Pan,Gaoqiang Lin,Ying Liu,Yingying Zhang,Xueyan Bian,Qifa Song,Guoqing Qian

DOI: https://doi.org/10.3389/fcimb.2022.957073

IF: 6.073

2022-12-20

Frontiers in Cellular and Infection Microbiology

Abstract:Background: Compared with traditional diagnostic methods (TDMs), rapid diagnostic methods for infectious diseases (IDs) are urgently needed. Metagenomic next-generation sequencing (mNGS) has emerged as a promising diagnostic technology for clinical infections. Methods: This retrospective observational study was performed at a tertiary hospital in China between May 2019 and August 2022. The chi-square test was used to compare the sensitivity and specificity of mNGS and TDMs. We also performed a subgroup analysis of the different pathogens and samples. Results: A total of 435 patients with clinical suspicion of infection were enrolled and 372 (85.5%) patients were finally categorized as the ID group. The overall sensitivity of mNGS was significantly higher than that of the TDMs (59.7% vs. 30.1%, P < 0.05). However, there was no significant difference in the overall specificity between the two methods (83.3% vs. 89.6%, P = 0.37). In patients with identified pathogens, the positive rates of mNGS for detecting bacteria (88.7%), fungi (87.9%), viruses (96.9%), and Nontuberculous mycobacteria (NTM; 100%) were significantly higher than those of TDMs ( P < 0.05). The positive rate of mNGS for detecting Mycobacterium tuberculosis was not superior to that of TDMs (77.3% vs. 54.5%, P = 0.11). The sensitivity rates of mNGS for pathogen identification in bronchoalveolar lavage fluid, blood, cerebrospinal fluid, pleural fluid, and tissue were 72.6%, 39.3%, 37.5%, 35.0% and 80.0%, respectively. Conclusion: With the potential for screening multiple clinical samples, mNGS has an overall advantage over TDMs. It can effectively identify pathogens, especially those that are difficult to identify using TDMs, such as NTM, chlamydia, and parasites.

immunology,microbiology
The clinical importance of metagenomic next-generation sequencing in detecting disease-causing microorganisms in cases of sepsis acquired in the community or hospital setting

Dan Zhang,Xingxing Li,Yu Wang,Yong Zhao,Hong Zhang

DOI: https://doi.org/10.3389/fmicb.2024.1384166

IF: 5.2

2024-04-16

Frontiers in Microbiology

Abstract:Objectives: Although metagenomic next-generation sequencing (mNGS) is commonly used for diagnosing infectious diseases, clinicians face limited options due to the high costs that are not covered by basic medical insurance. The goal of this research is to challenge this bias through a thorough examination and evaluation of the clinical importance of mNGS in precisely identifying pathogenic microorganisms in cases of sepsis acquired in the community or in hospitals. Methods: A retrospective observational study took place at a tertiary teaching hospital in China from January to December 2021. Data on 308 sepsis patients were collected, and the performance of etiological examination was compared between mNGS and traditional culture method. Results: Two hundred twenty-nine cases were observed in the community-acquired sepsis (CAS) group and 79 cases in the hospital-acquired sepsis (HAS) group. In comparison with conventional culture, mNGS showed a significantly higher rate of positivity in both the CAS group (88.21% vs. 25.76%, adj. P < 0.001) and the HAS group (87.34% vs. 44.30%, adj. P < 0.001), particularly across various infection sites and specimens, which were not influenced by factors like antibiotic exposure or the timing and frequency of mNGS technology. Sepsis pathogens detected by mNGS were broad, especially viruses, Mycobacterium tuberculosis , and atypical pathogens, with mixed pathogens being common, particularly bacterial-viral co-detection. Based on the optimization of antimicrobial therapy using mNGS, 58 patients underwent antibiotic de-escalation, two patients were switched to antiviral therapy, and 14 patients initiated treatment for tuberculosis, resulting in a reduction in antibiotic overuse but without significant impact on sepsis prognosis. The HAS group exhibited a critical condition, poor prognosis, high medical expenses, and variations in etiology, yet the mNGS results did not result in increased medical costs for either group. Conclusions: mNGS demonstrates efficacy in identifying multiple pathogens responsible for sepsis, with mixed pathogens of bacteria and viruses being prevalent. Variability in microbiological profiles among different infection setting underscores the importance of clinical vigilance. Therefore, the adoption of mNGS for microbiological diagnosis of sepsis warrants acknowledgment and promotion.

microbiology
Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection

Cuihong Qin,Shuguang Zhang,Yingying Zhao,Xianfei Ding,Fei Yang,Yangchao Zhao

DOI: https://doi.org/10.3389/fcimb.2023.1117987

IF: 6.073

2023-02-11

Frontiers in Cellular and Infection Microbiology

Abstract:Objective: To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) in sepsis and bloodstream infection (BSI). Methods: A retrospective analysis of patients diagnosed with sepsis and BSI at the First Affiliated Hospital of Zhengzhou University from January 2020 to February 2022 was conducted. All the patients underwent blood culture and were divided into mNGS group and non-mNGS group according to whether mNGS was performed or not. The mNGS group was further divided into early group ( 3 days) according to the time of mNGS inspection. Results: In 194 patients with sepsis and BSI, the positive rate of mNGS for identifying pathogens was significantly higher than that of blood culture (77.7% vs. 47.9%), and the detection period was shorter (1.41 ± 1.01 days vs. 4.82 ± 0.73 days); the difference was statistically significant ( p < 0.05). The 28-day mortality rate of the mNGS group ( n = 112) was significantly lower than that of the non-mNGS group ( n = 82) (47.32% vs. 62.20%, p = 0.043). The total hospitalization time for the mNGS group was longer than that for the non-mNGS group (18 (9, 33) days vs. 13 (6, 23) days, p = 0.005). There was no significant difference in the ICU hospitalization time, mechanical ventilation time, vasoactive drug use time, and 90-day mortality between the two groups ( p > 0.05). Sub-group analysis of patients in the mNGS group showed that the total hospitalization time and the ICU hospitalization time in the late group were longer than those in the early group (30 (18, 43) days vs. 10 (6, 26) days, 17 (6, 31) days vs. 6 (2, 10) days), and the ICU hospitalization time in the intermediate group was longer than that in the early group (6 (3, 15) days vs. 6 (2, 10) days); the differences were statistically significant ( p < 0.05). The 28-day mortality rate of the early group was higher than that of the late group (70.21% vs. 30.00%), and the difference was statistically significant ( p = 0.001). Conclusions: mNGS has the advantages of a short detection period and a high positive rate in the diagnosis of pathogens causing BSI and, eventually, sepsis. Routine blood culture combined with mNGS can significantly reduce the mortality of septic patients with BSI. Early detection using mNGS can shorten the total hospitalization time and the ICU hospitalization time of patients with sepsis and BSI.

immunology,microbiology
Metagenomic next-generation sequencing for the detection of pathogenic microorganisms in patients with pulmonary infection.

Jian'gang Shi,Yu Li,Jiemei Feng,Wenbin Wu,Peng-Hai Wei,Yifeng Luo,Lijuan Wu

American journal of translational research

Abstract:OBJECTIVE To explore the clinical value of metagenomic next-generation sequencing (mNGS) in diagnosing pulmonary infectious diseases. METHODS A retrospective analysis was performed on 82 patients with pulmonary infection who were admitted to the Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People's Hospital from January 2020 to December 2021. The pathogens were detected by mNGS and conventional methods (culture and PCR). Then, the type and number of detected pathogens, as well as the specificity and sensitivity, were compared between the two methods. In addition, the positive rates of bacteria, fungi, tubercle bacillus, and mixed infection in bronchoalveolar lavage fluid, sputum, pleural effusion, and blood detected by mNGS, and the advantage in required test time were evaluated. RESULTS More types and numbers of pathogens were detected by mNGS with a higher sensitivity but a lower specificity, as compared to the conventional detection methods (all P<0.05). The positive rates and integrity rates of bacteria, fungi, and tubercle bacillus detected by mNGS were higher than those by conventional methods (all P<0.05). Moreover, there was no difference in the overall sensitivity of mNGS among different sample types, but the sensitivities of mNGS in bronchoalveolar lavage fluid and sputum samples were significantly higher than those of conventional methods (both P<0.05). The average test time for mNGS was shorter than that of conventional methods. CONCLUSION mNGS can detect more types and numbers of pathogenic microorganisms, improve the detection sensitivity, and reduce the detection time in patients with pulmonary infection.

Medicine
Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice.

Qing Miao,Yuyan Ma,Qingqing Wang,Jue Pan,Yao Zhang,Wenting Jin,Yumeng Yao,Yi Su,Yingnan Huang,Mengran Wang,Bing Li,Huaying Li,Chunmei Zhou,Chun Li,Maosong Ye,Xiaoling Xu,Yongjun Li,Bijie Hu

DOI: https://doi.org/10.1093/cid/ciy693

IF: 20.999

2018-01-01

Clinical Infectious Diseases

Abstract:Background. Metagenomic next-generation sequencing (mNGS) was suggested to potentially replace traditional microbiological methodology because of its comprehensiveness. However, clinical experience with application of the test is relatively limited. Methods. From April 2017 to December 2017, 511 specimens were collected, and their retrospective diagnoses were classified into infectious disease (347 [67.9%]), noninfectious disease (119 [23.3%]), and unknown cases (45 [8.8%]). The diagnostic performance of pathogens was compared between mNGS and culture. The effect of antibiotic exposure on detection rate was also assessed. Results. The sensitivity and specificity of mNGS for diagnosing infectious disease were 50.7% and 85.7%, respectively, and these values outperformed those of culture, especially for Mycobacterium tuberculosis (odds ratio [OR], 4 [95% confidence interval {CI}, 1.7-10.8]; P < .01), viruses (mNGS only; P < .01), anaerobes (OR, infinity [95% CI, 1.71-infinity 0]; P < .01) and fungi (OR, 4.0 [95% CI, 1.6-10.3]; P < .01). Importantly, for mNGS-positive cases where the conventional method was inconclusive, 43 (61%) cases led to diagnosis modification, and 41 (58%) cases were not covered by empirical antibiotics. For cases where viruses were identified, broad-spectrum antibiotics were commonly administered (14/27), and 10 of 27 of these cases were suspected to be inappropriate. Interestingly, the sensitivity of mNGS was superior to that of culture (52.5% vs 34.2%; P < .01) in cases with, but not without, antibiotic exposure. Conclusions. mNGS could yield a higher sensitivity for pathogen identification and is less affected by prior antibiotic exposure, thereby emerging as a promising technology for detecting infectious diseases.
The clinical value of metagenomic next-generation sequencing in the microbiological diagnosis of skin and soft tissue infections

Qingqing Wang,Qing Miao,Jue Pan,Wenting Jin,Yuyan Ma,Yao Zhang,Yumeng Yao,Yi Su,Yingnan Huang,Bing Li,Mengran Wang,Na Li,Sishi Cai,Yu Luo,Chunmei Zhou,Honglong Wu,Bijie Hu

DOI: https://doi.org/10.1016/j.ijid.2020.09.007

IF: 12.073

2020-01-01

International Journal of Infectious Diseases

Abstract:Background: Metagenomic next-generation sequencing (mNGS), with its comprehensiveness, is widely applied in microbiological diagnosis. Etiological diagnosis is of paramount clinical importance in patients with skin and soft tissue infections (SSTIs). However, the clinical application of mNGS in SSTIs is relatively less studied. Materials and methods: From April 1, 2017 to December 31, 2019, 96 SSTI cases were collected. The positive rates of pathogens detected by mNGS and culture were compared by analyzing tissue samples, pus, swabs, and/or interstitial fluids obtained from the infected parts. Modification of the antibiotic treatment strategy due to mNGS was also assessed. Results: The sensitivity of mNGS for detecting pathogens in SSTI cases was superior to that of culture testing (67.7% vs 35.4%; p < 0.01). Significantly higher identification rates for viruses (10.4% vs 0.0%; p < 0.01) and anaerobes (11.5% vs 1.0%; p < 0.01) were obtained with mNGS compared to culture. Of note, rare pathogens such as Vibrio vulnificus and Bartonella henselae were also detected by mNGS. Importantly, the proportion of multi-pathogen SSTIs detected by mNGS was higher than that of multi-pathogen SSTIs detected by culture (16.7% vs 6.3%; p = 0.035). The rate of targeted antibiotic treatment was significantly higher in mNGS-positive cases than in mNGS-negative cases (41.7% vs 3.8%; p < 0.01). In culture-negative and mNGS-positive cases, the improvement rate was higher than that in mNGS-negative cases, but this was not statistically significant (75.0% vs 73.1%; p = 0.864). Conclusions: mNGS is a promising tool for the etiological diagnosis of SSTIs, particularly in identifying viruses, anaerobes, and multi-pathogen infections. The application of mNGS testing in clinical practice could change antibiotic treatment strategies and partly benefit clinical outcomes. (c) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Diagnostic performance of metagenomic sequencing in patients with suspected infection: a large-scale retrospective study

Ziyang Li,Li Tan,Jialiang Zhang,Qichen Long,Zhiyang Chen,Zhongyuan Xiang,Weimin Wu,Zhe Guo,Huifang Liu,Bingxue Hu,Bin Yang,Min Hu

DOI: https://doi.org/10.3389/fcimb.2024.1463081

2024-09-06

Abstract:Background: Metagenomic next-generation sequencing (mNGS) has been widely reported to identify pathogens in infectious diseases (IDs). In this work, we intended to investigate the diagnostic value and clinical acceptance of paired-samples mNGS as compared to the culture method. Methods: A total of 361 patients with suspected infection were retrospectively included. With reference to the clinical diagnosis, we compared the diagnostic performance and clinical acceptance in pathogen detection between mNGS and culture tests. Moreover, the pathogen concordance of paired blood and respiratory tract (RT) samples in mNGS assay was investigated. Results: Among 511 samples, 62.04% were shown to be pathogen positive by mNGS, and that for clinical diagnosis was 51.86% (265/511). When compared to culture assay (n = 428), mNGS had a significantly higher positivity rate (51.87% vs. 33.18%). With reference to the clinical diagnosis, the sensitivity of mNGS outperformed that of culture (89.08% vs. 56.72%). Importantly, mNGS exhibited a clinically accepted rate significantly superior to that of culture. In addition, the mNGS result from 53 paired blood and RT samples showed that most pairs were pathogen positive by both blood and RT, with pathogens largely being partially matched. Conclusion: Through this large-scale study, we further illustrated that mNGS had a clinically accepted rate and sensitivity superior to those of the traditional culture method in diagnosing infections. Moreover, blood and paired RT samples mostly shared partial-matched positive pathogens, especially for pathogens with abundant read numbers in RT, indicating that both blood and RT mNGS can aid the identification of pathogens for respiratory system infection.
Clinical Application and Influencing Factor Analysis of Metagenomic Next-Generation Sequencing (mNGS) in ICU Patients With Sepsis

Limin Sun,Shuguang Zhang,Ziyue Yang,Fei Yang,Zhenhua Wang,Hongqiang Li,Yaoguang Li,Tongwen Sun

DOI: https://doi.org/10.3389/fcimb.2022.905132

IF: 6.073

2022-07-13

Frontiers in Cellular and Infection Microbiology

Abstract:Objective: To analyze the clinical application and related influencing factors of metagenomic next-generation sequencing (mNGS) in patients with sepsis in intensive care unit (ICU). Methods: The study included 124 patients with severe sepsis admitted to the ICU in the First Affiliated Hospital of Zhengzhou University from June 2020 to September 2021. Two experienced clinicians took blood mNGS and routine blood cultures of patients meeting the sepsis diagnostic criteria within 24 hours after sepsis was considered, and collection the general clinical data. Results: mNGS positive rate was higher than traditional blood culture (67.74% vs. 19.35%). APACHE II score [odds ratio ( OR )=1.096], immune-related diseases ( OR =6.544), and hypertension ( OR =2.819) were considered as positive independent factors for mNGS or culture-positive. The sequence number of microorganisms and pathogen detection (mNGS) type had no effect on prognosis. Age ( OR =1.016), female ( OR =5.963), myoglobin ( OR =1.005), and positive virus result ( OR =8.531) were independent risk factors of sepsis mortality. Adjusting antibiotics according to mNGS results, there was no statistical difference in the prognosis of patients with sepsis. Conclusion: mNGS has the advantages of rapid and high positive rate in the detection of pathogens in patients with severe sepsis. Patients with high APACHE II score, immune-related diseases, and hypertension are more likely to obtain positive mNGS results. The effect of adjusting antibiotics according to mNGS results on the prognosis of sepsis needs to be further evaluated.

immunology,microbiology
Diagnostic Value of Metagenomic Next-Generation Sequencing for Pulmonary Infection in Intensive Care Unit and Non-Intensive Care Unit Patients

Jing-Jiang Zhou,Wei-Chao Ding,Yan-Cun Liu,Yu-Lei Gao,Lei Xu,Run-Lu Geng,Ying Ye,Yan-Fen Chai

DOI: https://doi.org/10.3389/fcimb.2022.929856

IF: 6.073

2022-08-15

Frontiers in Cellular and Infection Microbiology

Abstract:Objective: To evaluate the diagnostic performance of metagenomic next-generation sequencing (mNGS) and culture in pathogen detection among intensive care unit (ICU) and non-ICU patients with suspected pulmonary infection. Methods: In this prospective study, sputum samples were collected from patients with suspected pulmonary infection for 2 consecutive days and then subjected to DNA or RNA sequencing by mNGS or culture; 62 ICU patients and 60 non-ICU patients were admitted. In the end, comparisons were made on the pathogen species identified by mNGS and culture, the overall performance of these two methods in pathogen detection, and the most common pathogens detected by mNGS between the ICU and non-ICU groups. Results: In DNA and RNA sequencing, the positive rate of pathogen detection reached 96.69% (117/121) and 96.43% (108/112), respectively. In culture tests, the positive rate of the pathogen was 39.34% (48/122), much lower than that of DNA and RNA sequencing. In general, the positive rate of pathogen detection by sputum mNGS was significantly higher than that of sputum culture in the total and non-ICU groups (p < 0.001) but did not show a significant difference when compared to the result of sputum culture in the ICU group (p = 0.08). Haemophilus spp., Candida albicans , Enterococcus spp., and viruses from the mNGS results were excluded before comparing the overall performance of these two methods in pathogen detection. Specifically, among the 10 most common bacteria implied from the mNGS results, significant differences were observed in the number of cases of Haemophilus parainfluenzae , Acinetobacter baumannii , Klebsiella pneumoniae , Pseudomonas aeruginosa , Stenotrophomonas maltophilia , Staphylococcus aureus , and Enterococcus faecalis between the ICU and non-ICU groups (p < 0.05). Conclusions: This study demonstrated the superiority of mNGS over culture in detecting all kinds of pathogen species in sputum samples. These results indicate that mNGS may serve as a valuable tool to identify pathogens, especially for ICU patients who are more susceptible to mixed infections.

immunology,microbiology
Diagnostic performance and clinical impact of blood metagenomic next-generation sequencing in ICU patients suspected monomicrobial and polymicrobial bloodstream infections

Qilong Liu,Xiaojing Liu,Bingxue Hu,Huan Xu,Rongqing Sun,Pengfei Li,Yunwei Zhang,Hongfu Yang,Ning Ma,Xiaoge Sun

DOI: https://doi.org/10.3389/fcimb.2023.1192931

IF: 6.073

2023-06-26

Frontiers in Cellular and Infection Microbiology

Abstract:Introduction: Early and effective application of antimicrobial medication has been evidenced to improve outcomes of patients with bloodstream infection (BSI). However, conventional microbiological tests (CMTs) have a number of limitations that hamper a rapid diagnosis. Methods: We retrospectively collected 162 cases suspected BSI from intensive care unit with blood metagenomics next-generation sequencing (mNGS) results, to comparatively evaluate the diagnostic performance and the clinical impact on antibiotics usage of mNGS. Results and discussion: Results showed that compared with blood culture, mNGS detected a greater number of pathogens, especially for Aspergillus spp , and yielded a significantly higher positive rate. With the final clinical diagnosis as the standard, the sensitivity of mNGS (excluding viruses) was 58.06%, significantly higher than that of blood culture (34.68%, P <0.001). Combing blood mNGS and culture results, the sensitivity improved to 72.58%. Forty-six patients had infected by mixed pathogens, among which Klebsiella pneumoniae and Acinetobacter baumannii contributed most. Compared to monomicrobial, cases with polymicrobial BSI exhibited dramatically higher level of SOFA, AST, hospitalized mortality and 90-day mortality ( P <0.05). A total of 101 patients underwent antibiotics adjustment, among which 85 were adjusted according to microbiological results, including 45 cases based on the mNGS results (40 cases escalation and 5 cases de-escalation) and 32 cases on blood culture. Collectively, for patients suspected BSI in critical condition, mNGS results can provide valuable diagnostic information and contribute to the optimizing of antibiotic treatment. Combining conventional tests with mNGS may significantly improve the detection rate for pathogens and optimize antibiotic treatment in critically ill patients with BSI.

immunology,microbiology
CC-16 as a Biomarker in Chronic Obstructive Pulmonary Disease

Jennifer A. Dickens,D. Lomas

DOI: https://doi.org/10.3109/15412555.2012.718926

2012-09-27

Abstract:Clara cell secretory protein-16 (CC-16, CCSP, CC-10 or uteroglobin) is a small secreted disulphide-bridged dimeric protein that is a member of the secretoglobulin family [1]. It is secreted by non-...
Incremental Value of Metagenomic Next Generation Sequencing for the Diagnosis of Suspected Focal Infection in Adults.

Hao-Cheng Zhang,Jing-Wen Ai,Peng Cui,Yi-Min Zhu,Wu Hong-Long,Yong-Jun Li,Wen-Hong Zhang

DOI: https://doi.org/10.1016/j.jinf.2019.08.012

IF: 28.2

2019-01-01

Journal of Infection

Abstract:Objectives: Microbiological diagnosis is essential during clinical management of focal infections. Metagenomic next generation sequencing (mNGS) has been reported as a promising diagnostic tool in infectious diseases. However, little is known about the clinical utility of mNGS in focal infections. Methods: We conducted a single-center retrospective study to investigate impact of mNGS on focal infection diagnosis and compared it with conventional methods, including culture, pathological examination, Xpert MTB/RIF, etc. 98 suspected focal infections cases were enrolled, and medical records were reviewed to determine their rates of detection, time-to-identification, and clinical outcomes. Results: mNGS showed a satisfying diagnostic positive percent agreement of 86.30% (95% CI: 75.79-92.88%) in a variety of tissues, compared to 45.21% (95% CI: 33.68-57.24%) for culture and 57.53% (95% CI: 45.43-68.84%)f for conventional methods (p < 0.0125), and detected an extra 34 pathogenic microorganisms. Time requirement for pathogen identification using mNGS ranges from 31 h to 55 h, which showed an advantage over culture. (82.36 h; 95%CI: 65.83, 98.89; P < 0.05) Conclusions: mNGS showed promising potential in pathogenic diagnosis during focal infections and might enable clinicians to make more timely and targeted therapeutic decisions. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
Near field of non-resonant system of transverse slots in rectangular waveguide

S. Berdnik,V. Katrich,M. Nesterenko,V. Karazin

DOI: https://doi.org/10.1109/CRMICO.2005.1564943

Abstract:Presented in this paper is the research of electromagnetic waves radiation by system of non-resonant transverse slots in the broad wall of rectangular waveguide. Such slot structure is the kind of leaky-wave antenna. The investigation of the spatial near field distribution of the system was carried out.
The Comparison of Metagenomic Next-Generation Sequencing with Conventional Microbiological Tests for Identification of Pathogens and Antibiotic Resistance Genes in Infectious Diseases

Hongzhi Lu,Li Ma,Hong Zhang,Li Feng,Ying Yu,Yihan Zhao,Li Li,Yujiao Zhou,Li Song,Wushuang Li,Jiangman Zhao,Lanxiang Liu

DOI: https://doi.org/10.2147/IDR.S370964

2022-10-22

Infection and Drug Resistance

Abstract:Hongzhi Lu, 1 Li Ma, 1 Hong Zhang, 1 Li Feng, 1 Ying Yu, 1 Yihan Zhao, 1 Li Li, 1 Yujiao Zhou, 1 Li Song, 2, 3 Wushuang Li, 2, 3 Jiangman Zhao, 2, 3 Lanxiang Liu 4 1 Department of Infectious Diseases, First Hospital of Qinhuangdao, Qinhuangdao, Hebei, 066000, People's Republic of China; 2 Shanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai, 201204, People's Republic of China; 3 Shanghai Zhangjiang Institute of Medical Innovation, Shanghai, 201204, People's Republic of China; 4 Medical Imaging Center, First Hospital of Qinhuangdao, Qinhuangdao, Hebei, 066000, People's Republic of China Correspondence: Lanxiang Liu, Department of Medical Imaging Center, First Hospital of Qinhuangdao, 258 Wenhua Road, Qinhuangdao, 066000, Hebei, People's Republic of China, Email Background: Metagenomic next-generation sequencing (mNGS) has been widely studied, due to its ability of detecting all the microbial genetic information unbiasedly in a sample at one time and not relying on traditional culture. However, the application of mNGS in the diagnosis of clinical pathogens remains challenging. Methods: From December 2019 to March 2021, 134 specimens including Broncho alveolar lavage fluid (BAFL), blood, sputum, cerebrospinal fluid (CSF), bile, pleural fluid, pus, were continuously collected in The First Hospital of Qinhuangdao, and their retrospective diagnoses were classified into infectious disease (128, 95.5%) and noninfectious disease (6, 4.5%). The pathogen-detection performance of mNGS was compared with conventional microbiological tests (CMT) and culture method. In addition, the antibiotic resistance genes (ARGs) and evolutionary relationship of common drug-resistant A. baumannii were also analyzed. Results: Compared with CMT and culture methods, mNGS showed higher sensitivity in pathogen detection (74.2% vs 57.8%; P < 0.001 and 66.3% vs 31.7%; P < 0.001, respectively). Importantly, for cases that mNGS-positive only, 18 (35%) cases result in diagnosis modification, and 7 (23%) cases confirmed the clinical diagnosis. In 17 cases that A. baumannii were both detected in mNGS and culture, ade genes were the most frequently detected ARGs (from 13 cases), followed by sul2 and APH(3")-Ib (both from 12 cases). High consistency was observed among these ARGs and the related phenotype (100% for ade genes, 91.6% for sul2 and APH(3")-Ib). A. baumannii strains were classified into three groups, and most were well-clustered. It suggested those strains may be the epidemic strains. Conclusion: In our study, mNGS had a higher sensitivity than CMT and culture method. And the result of ARGs frequency and cluster analysis of A. baumannii was of great significance to the anti-infective therapy. Keywords: metagenomic next-generation sequencing, sensitivity, antibiotic resistance genes, infection, conventional microbiological tests Infection is one of the main causes of death in critically ill patients. With the emergence of new pathogenic microorganisms, increasing number of drug-resistant pathogens and immunosuppressive hosts, the incidence and mortality rate of infectious diseases remain high. 1–3 The traditional pathogen detection technology is mainly based on microbial culture which depends on the vitality of pathogens and media type, incubation temperature, oxygen levels, etc. The results of traditional culture method indicated that only 38% of patients with community-acquired pneumonia can be diagnosed by traditional detection method. 4 Serological detection technology based on antigen or antibody is fast and easy to operate, but prior knowledge is necessary, while the detection sensitivity and specificity are also limited. 5 With the development of molecular biology technology, nucleic acid detection has become the mainstream development trend of pathogen detection. It gets rid of the dependence of traditional detection on pathogen isolation and culture, and significantly improves the sensitivity of pathogen detection. In recent years, with the development and application of high-throughput sequencing technology in pathogen detection, mNGS has shown significant advantages compared to other detection methods. 6,7 However, the etiological diagnosis of clinical infection remains challenging. 8–10 Whether the detection results reflect the real infection status of patient needs to be combined with the clinical situation for comprehensive evaluation since mNGS only detects nucleic acids (including DNA and RNA) in samples. In order to establish the standard of clinical applicati -Abstract Truncated-

pharmacology & pharmacy,infectious diseases
The microbiological diagnostic performance of metagenomic next-generation sequencing in patients with sepsis

Di Ren,Chao Ren,Renqi Yao,Lin Zhang,Xiaomin Liang,Guiyun Li,Jiaze Wang,Xinke Meng,Jia Liu,Yu Ye,Haoli Li,Sha Wen,Yanhong Chen,Dan Zhou,Xisi He,Xiaohong Li,Kai Lai,Ying Li,Shuiqing Gui

DOI: https://doi.org/10.1186/s12879-021-06934-7

IF: 3.7

2021-12-01

BMC Infectious Diseases

Abstract:Abstract Background In this study, we aimed to perform a comprehensive analysis on the metagenomic next-generation sequencing for the etiological diagnosis of septic patients, and further to establish optimal read values for detecting common pathogens. Methods In this single-center retrospective study, septic patients who underwent pathogen detection by both microbial culture and metagenomic next-generation sequencing in the intensive care unit of the Second People’s Hospital of Shenzhen from June 24, 2015, to October 20, 2019, were included. Results A total of 193 patients with 305 detected specimens were included in the final analysis. The results of metagenomic next-generation sequencing showed significantly higher positive rates in samples from disparate loci, including blood, bronchoalveolar lavage fluid, and cerebrospinal fluid, as well as in the determination of various pathogens. The optimal diagnostic reads were 2893, 1825.5, and 892.5 for Acinetobacter baumannii, Pseudomonas aeruginosa , and Klebsiella pneumoniae , respectively. Conclusions The metagenomic next-generation sequencing is capable of identifying multiple pathogens in specimens from septic patients, and shows significantly higher positive rates than culture-based diagnostics. The optimal diagnostic reads for frequently detected microbes might be useful for the clinical application of metagenomic next-generation sequencing in terms of timely and accurately determining etiological pathogens for suspected and confirmed cases of sepsis due to well-performed data interpretation.

infectious diseases

[Internal quality management: use of a patient questionnaire in a urological university clinic. Results of a pilot project].

Diagnostic accuracy of metagenomic next-generation sequencing in diagnosing infectious diseases: a meta-analysis

Higher diagnostic value of metagenomic next-generation sequencing in acute infection than chronic infection: a multicenter retrospective study

The diagnostic value of metagenomic next-generation sequencing in critically ill patients with sepsis: A retrospective cohort study

Clinical application of metagenomic next-generation sequencing for the diagnosis of suspected infection in adults: A cross-sectional study

Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital

The clinical application of metagenomic next-generation sequencing in infectious diseases at a tertiary hospital in China

The clinical importance of metagenomic next-generation sequencing in detecting disease-causing microorganisms in cases of sepsis acquired in the community or hospital setting

Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection

Metagenomic next-generation sequencing for the detection of pathogenic microorganisms in patients with pulmonary infection.

Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice.

The clinical value of metagenomic next-generation sequencing in the microbiological diagnosis of skin and soft tissue infections

Diagnostic performance of metagenomic sequencing in patients with suspected infection: a large-scale retrospective study

Clinical Application and Influencing Factor Analysis of Metagenomic Next-Generation Sequencing (mNGS) in ICU Patients With Sepsis

Diagnostic Value of Metagenomic Next-Generation Sequencing for Pulmonary Infection in Intensive Care Unit and Non-Intensive Care Unit Patients

Diagnostic performance and clinical impact of blood metagenomic next-generation sequencing in ICU patients suspected monomicrobial and polymicrobial bloodstream infections

CC-16 as a Biomarker in Chronic Obstructive Pulmonary Disease

Incremental Value of Metagenomic Next Generation Sequencing for the Diagnosis of Suspected Focal Infection in Adults.

Near field of non-resonant system of transverse slots in rectangular waveguide

The Comparison of Metagenomic Next-Generation Sequencing with Conventional Microbiological Tests for Identification of Pathogens and Antibiotic Resistance Genes in Infectious Diseases

The microbiological diagnostic performance of metagenomic next-generation sequencing in patients with sepsis